Press "Enter" to skip to content

Zydus Cadila gets USFDA nod to market generic drug

The company has received the final approval from the US Food and Drug Administration (USFDA) to market Albendazole Tablets USP in strength of 200 mg, Zydus Cadila said in a statement.

Original source: https://health.economictimes.indiatimes.com/news/pharma/zydus-cadila-gets-usfda-nod-to-market-generic-drug/67121254?utm_source=RSS&utm_medium=ETRSS

Also Read:   HLL Life to go on the block soon as disinvestment gathers pace